Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting - PubMed (original) (raw)

doi: 10.1089/acm.2015.0315. Epub 2016 Apr 26.

Diego Cortinovis 2, Maria Cossu Rocca 3, Fausto Roila 4, Patrizia Seminara 5, Alessandra Fabi 6, Stefania Canova 2, Elena Verri 3, Sonia Fatigoni 4, Alessandro Iannace 5, Fabio Macchi 7, Carla Ripamonti 1

Affiliations

Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting

Paolo Bossi et al. J Altern Complement Med. 2016 Jun.

Abstract

Patients with cancer frequently use dietary supplementation and herbal therapies to control symptoms of disease and adverse effects of cancer therapy. Despite the widespread use of dietary supplementation and herbal therapies in oncology, robust scientific evidence in this area is lacking. Not only do these products need to be tested in large and well-designed observational or randomized studies, but their manufacturing process must be improved to achieve higher levels of standardization in product quality. Ginger is frequently used to counteract chemotherapy-induced nausea and vomiting (CINV), and some suggestions that it might be effective against CINV come from randomized and/or crossover clinical trials. However, several limitations in the methods of these studies limit their power and generalizability. The authors are conducting a randomized, double-blind study with a large sample size and homogeneous inclusion criteria in order to evaluate the efficacy of a well-standardized ginger extract in reducing nausea in patients with cancer. The widespread use of standardized herbal therapies and natural components among patients requires that scientific and rigorous research strategies are applied in this field to guide the physicians and the patients in safer use.

PubMed Disclaimer

References

    1. Ebel MD, Rudolph I, Keinki C, et al. Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine. J Cancer Res Clin Oncol 2015;141:1449–1455 -PMC -PubMed
    1. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer 2008;113:1048–1057 -PubMed
    1. Frenkel M, Sierpina V. The use of dietary supplements in oncology. Curr Oncol Rep 2014;16:411. -PubMed
    1. Gaziano JM, Sesso HD, Christen WG, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012;308:1871–1880 -PMC -PubMed
    1. US Department of Agriculture and US Department of Health and Human Services. 2010. Online document at: http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm Accessed June6, 2015

MeSH terms

Substances

LinkOut - more resources